198 related articles for article (PubMed ID: 6320902)
1. Stimulation by human interleukin 1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not by human osteoblasts in vitro.
Gowen M; Wood DD; Ihrie EJ; Meats JE; Russell RG
Biochim Biophys Acta; 1984 Feb; 797(2):186-93. PubMed ID: 6320902
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 induces chondrocyte protease production: the development of collagenase inhibitors.
Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G
Agents Actions; 1987 Aug; 21(3-4):328-30. PubMed ID: 2825481
[TBL] [Abstract][Full Text] [Related]
3. Induction of neutral proteinase and prostanoid production in bovine nasal chondrocytes by interleukin-1 and tumor necrosis factor alpha: modulation of these cellular responses by interleukin-6 and platelet-derived growth factor.
Smith RJ; Justen JM; Ulrich RG; Lund JE; Sam LM
Clin Immunol Immunopathol; 1992 Aug; 64(2):135-44. PubMed ID: 1322806
[TBL] [Abstract][Full Text] [Related]
4. Stromelysin 1, neutrophil collagenase, and collagenase 3 do not play major roles in a model of chondrocyte mediated cartilage breakdown.
Kozaci LD; Brown CJ; Adcocks C; Galloway A; Hollander AP; Buttle DJ
Mol Pathol; 1998 Oct; 51(5):282-6. PubMed ID: 10193524
[TBL] [Abstract][Full Text] [Related]
5. Proteoglycan- and collagen-degrading enzymes from human interleukin 1-stimulated chondrocytes from several species: proteoglycanase and collagenase inhibitors as potentially new disease-modifying antiarthritic agents.
DiPasquale G; Caccese R; Pasternak R; Conaty J; Hubbs S; Perry K
Proc Soc Exp Biol Med; 1986 Nov; 183(2):262-7. PubMed ID: 3020566
[TBL] [Abstract][Full Text] [Related]
6. Neutral proteinases from articular chondrocytes in culture. 2. Metal-dependent latent neutral proteoglycanase, and inhibitory activity.
Sapolsky AI; Malemud CJ; Norby DP; Moskowitz RW; Matsuta K; Howell DS
Biochim Biophys Acta; 1981 Mar; 658(1):138-47. PubMed ID: 6783102
[TBL] [Abstract][Full Text] [Related]
7. Mononuclear cell factor modulates the concomitant release of proteoglycan and latent proteinase by human articular cartilage in organ culture.
Campbell IK; Mort JS; Golds EE; Roughley PJ
Agents Actions Suppl; 1986; 18():43-6. PubMed ID: 3524149
[No Abstract] [Full Text] [Related]
8. Effects of interleukin-1 and anti-inflammatory drugs on the degradation of human articular cartilage.
Shinmei M; Kikuchi T; Masuda K; Shimomura Y
Drugs; 1988; 35 Suppl 1():33-41. PubMed ID: 2834169
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 stimulates the secretion of proteoglycan- and collagen-degrading proteases by rabbit articular chondrocytes.
Pasternak RD; Hubbs SJ; Caccese RG; Marks RL; Conaty JM; DiPasquale G
Clin Immunol Immunopathol; 1986 Dec; 41(3):351-67. PubMed ID: 3536222
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the effect of interleukin 6 and interleukin 1 on collagenase and proteoglycan production by chondrocytes.
Kandel RA; Petelycky M; Dinarello CA; Minden M; Pritzker KP; Cruz TF
J Rheumatol; 1990 Jul; 17(7):953-7. PubMed ID: 2170644
[TBL] [Abstract][Full Text] [Related]
11. Effects of growth factors and interleukin-1 alpha on proteoglycan and type II collagen turnover in bovine nasal and articular chondrocyte pellet cultures.
Xu C; Oyajobi BO; Frazer A; Kozaci LD; Russell RG; Hollander AP
Endocrinology; 1996 Aug; 137(8):3557-65. PubMed ID: 8754787
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by interleukin-1 and the selective inhibition of type II collagen cleavage by collagenase.
Billinghurst RC; Wu W; Ionescu M; Reiner A; Dahlberg L; Chen J; van Wart H; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):664-72. PubMed ID: 10728761
[TBL] [Abstract][Full Text] [Related]
13. Production of cytokines by chondrocytes and its role in proteoglycan degradation.
Shinmei M; Masuda K; Kikuchi T; Shimomura Y; Okada Y
J Rheumatol Suppl; 1991 Feb; 27():89-91. PubMed ID: 2027138
[TBL] [Abstract][Full Text] [Related]
14. Studies on the release of proteolytic enzymes during synovium-induced cartilage breakdown in vitro and the actions of anti-inflammatory drugs.
Crossley MJ; Hunneyball IM
Biochem Pharmacol; 1984 Apr; 33(8):1263-71. PubMed ID: 6324820
[TBL] [Abstract][Full Text] [Related]
15. The production in culture of metalloproteinases and an inhibitor by joint tissues from normal rabbits, and from rabbits with a model arthritis. II. Articular cartilage.
Murphy G; Cambray GJ; Virani N; Page-Thomas DP; Reynolds JJ
Rheumatol Int; 1981; 1(1):17-20. PubMed ID: 6287558
[TBL] [Abstract][Full Text] [Related]
16. In vitro activation of human chondrocytes and synoviocytes by a human interleukin-1-like factor.
McGuire-Goldring MB; Meats JE; Wood DD; Ihrie EJ; Ebsworth NM; Russell RG
Arthritis Rheum; 1984 Jun; 27(6):654-62. PubMed ID: 6610426
[TBL] [Abstract][Full Text] [Related]
17. Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes.
Gadher SJ; Eyre DR; Wotton SF; Schmid TM; Woolley DE
Matrix; 1990 Jul; 10(3):154-63. PubMed ID: 2170828
[TBL] [Abstract][Full Text] [Related]
18. Potent collagenase inhibitors prevent interleukin-1-induced cartilage degradation in vitro.
Nixon JS; Bottomley KM; Broadhurst MJ; Brown PA; Johnson WH; Lawton G; Marley J; Sedgwick AD; Wilkinson SE
Int J Tissue React; 1991; 13(5):237-41. PubMed ID: 1666894
[TBL] [Abstract][Full Text] [Related]
19. Modulation of connective tissue metabolism by partially purified human interleukin 1.
Richardson HJ; Elford PR; Sharrard RM; Meats JE; Russell RG
Cell Immunol; 1985 Jan; 90(1):41-51. PubMed ID: 3871364
[TBL] [Abstract][Full Text] [Related]
20. Co-operation between interleukin-1 and the fibrinolytic system in the degradation of collagen by articular chondrocytes.
Cruwys SC; Davies DE; Pettipher ER
Br J Pharmacol; 1990 Jul; 100(3):631-5. PubMed ID: 2167739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
